• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Anvisa Approves Cabometyx (capazantinib levomalate) for advanced or metastatic kidney cancer

    ANVISA

    Lupin launches contraceptive drug in the US market

    ECONOMIC TIMES

    Lupin`s Generic Drospirenone: Levomefolate Calcium: Estradiol Receives Approval In US

    FDA

    Lupin gets USFDA nod for contraceptive tablet `Tydemy` for women

    BUSINESS-STANDARD

    Lupin’s Generic Tydemy (Drospirenone; Ethinyl Estradiol; Levomefolate Calcium ) Receives Approval In US

    FDA

    Watson Labs Generics "Drospirenone;Ethinyl Estradiol;Levomefolate Calcium;Levomefolate Calcium" Approved In US

    FDA

    Watson`s Generic (Drospirenone; Ethinyl Estradiol; Levomefolate Calcium; Levomefolate Calcium) Approved in US For Ovulation and Menstruation

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.